Southern Sweden's university hospital and Lund University's cancer centre, known for the population-wide SCAN-B breast cancer sequencing project.
Skåne University Hospital in Lund and Malmö is the tertiary cancer centre for southern Sweden, and Lund University Cancer Centre coordinates research across its Medicon Village campus. Åke Borg and Lao Saal established the Sweden Cancerome Analysis Network-Breast (SCAN-B), which has sequenced the transcriptomes of breast cancers from consecutive patients across the region since 2010 and reports gene expression subtypes back into care, and Lund groups are strong in melanoma and prostate genomics, paediatric oncology and radiation physics linked to the MAX IV synchrotron. Lund also spun out antibody company BioInvent and hosts a Swedish node for CAR-T and haematological trials.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Skåne University Hospital, including child institutions. 521 works · 4,154 citations · 81% open access · 9% clinical trials · 1% reviews.
Physician and hospital director of Skåne University Hospital, the university hospital serving southern Sweden and home to Lund's cancer services.
Led MASAI, the first randomised trial of AI-supported mammography screening, which found more cancers with half the radiologist workload.
Pamela Buchwald represents Skåne University Hospital / Lund University Cancer Centre in the Organisation of European Cancer Institutes, which lists the centre among its members in Sweden.
This is the population-based prevalence for the two label thresholds in early TNBC, and it shows the KEYNOTE-355 CPS 10 gate would admit only about a quarter of unselected patients.
It is the best population-based estimate of how much TNBC is homologous recombination deficient, shows that most of it is not germline BRCA, and argues that whole-genome sequencing at diagnosis could stratify trials and pick out the low group that needs something other than DNA-damaging chemotherapy.
Shares RNA sequencing & expression profiling, Whole-exome & whole-genome sequencing, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares PAM50 / intrinsic subtypes, RNA sequencing & expression profiling, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares RNA sequencing & expression profiling, Whole-exome & whole-genome sequencing, Melanoma, Triple-negative breast cancer (TNBC).
Shares Kristina Lång, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study, Melanoma, Prostate cancer.
Shares PAM50 / intrinsic subtypes, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer.
Shares PAM50 / intrinsic subtypes, Germline (hereditary) testing, Triple-negative breast cancer (TNBC).
Shares Germline (hereditary) testing, Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, Prostate cancer.